| 000 | 01067 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515170811.0 | ||
| 264 | 0 | _c20090709 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1078-1439 | ||
| 024 | 7 |
_a10.1016/j.urolonc.2009.01.026 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, Daniel W | |
| 245 | 0 | 0 |
_aBeyond PSA: utility of novel tumor markers in the setting of elevated PSA. _h[electronic resource] |
| 260 |
_bUrologic oncology _c |
||
| 300 |
_a315-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xanalysis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
| 650 | 0 | 4 | _aDNA Methylation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOncogene Proteins, Fusion _xgenetics |
| 650 | 0 | 4 |
_aProstate-Specific Antigen _xanalysis |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 773 | 0 |
_tUrologic oncology _gvol. 27 _gno. 3 _gp. 315-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.urolonc.2009.01.026 _zAvailable from publisher's website |
| 999 |
_c18843091 _d18843091 |
||